FDA Approves SAPIEN 3 Platform for Asymptomatic Severe Aortic Stenosis
MONDAY, May 5, 2025 -- The U.S. Food and Drug Administration has approved the SAPIEN 3 platform, a transcatheter aortic valve replacement (TAVR) therapy, for patients with severe aortic stenosis without symptoms. The approval is the first for TAVR...
Read more »
Pharmaceutical news
Salmonella Outbreak in 6 States Tied to Backyard Poultry, CDC Says
COVID Boosters Might Not Be Updated For Next Season, FDA Commissioner Says
Marijuana Use While Pregnant Linked to Preterm Birth, Low Birth Weight
$800M in LGBTQ Health Research Funding Nixed by Trump Administration
Second Opinions Don't Significantly Delay Breast Cancer Treatment
RSV Antibody Treatment Effective For Babies
Follow-Up Test For High Blood Pressure Condition Not Worthwhile, Researchers Say
1 in 10 Doctors is Burned Out
Nuts, Seeds OK For People With Diverticulitis, Study Says
Cancer Patient Avoided Side Effects With New Advance In Radiation Therapy
Power Outages Up Odds of Carbon Monoxide-Related ED Visits Among Children
Emergency Department Visits for Asthma Increased During 2023 Wildfires
No-Touch Vein Harvesting Reduces Vein Graft Occlusion at Three Years
Transcranial Pulse Current Stimulation Beneficial in Autism
